Addition of tranexamic acid to a traumatic injury massive transfusion protocol

American Journal of Health-System Pharmacy

Volumn 72, Issue 12, 2015, Pages 1059-1064

  Farrell, Natalija M ^a   Wing, Heidi A ^b   Burke, Peter A ^b,c   Huiras, Paul ^b  

^a Georgia Poison Center   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ARTICLE; BLOOD TRANSFUSION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PHARMACY; CLINICAL PROTOCOL; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HOSPITAL CARE; HUMAN; INJURY SEVERITY; INTENSIVE CARE; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MASSIVE TRANSFUSION PROTOCOL; MEDICAL EDUCATION; MEDICATION COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; TOTAL QUALITY MANAGEMENT; TRAUMATOLOGY; ADOLESCENT; ADULT; COOPERATION; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PROCEDURES; UNITED STATES; UNIVERSITY HOSPITAL; WOUNDS AND INJURIES; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; ANTIFIBRINOLYTIC AGENTS; BOSTON; COOPERATIVE BEHAVIOR; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; TRANEXAMIC ACID; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84957635218     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp140466     Document Type: Article

References (15)

1. American Association for the Surgery of Trauma. Trauma facts, www.aast.org/TraumaFacts.aspx (accessed 2014 Mar 1).
2. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentation, and therapeutic considerations. J Trauma. 2006; 60(suppl):S3-11.
3. Howard BM, Daley AT, Cohen MJ. Prohemostatic interventions in trauma: resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other interventions. Semin Thromb Hemost. 2012; 38:250-8.
4. Dawes R, Thomas GO. Battlefield resuscitation. Curr Opin Crit Care. 2009; 15:527-35.
5. Schuster KM, Davis KA, Lui FY et al. The status of massive transfusion protocols in United States trauma centers: massive transfusion or massive confusion? Transfusion. 2010; 50:1545-51.
6. Cotton BA, Gunter OL, Isbell J et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization, J Trauma. 2008; 64:1177-83.
7. Shakur H, Roberts I, Bautista R et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376:23-32.
8. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg. 2012;147:113-9.
9. Cyklokapron (tranexamic acid) package insert. New York: Pfizer; 2013 May.
10. Roberts I, Shakur H, Afolabi A et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377:1096-101.
11. Napolitano LM, Cohen M J, Cotton BA et al. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013;74:1575-86.
12. Valle EJ, Allen CJ, Van Haren RM et al. Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg. 2014;76:1373-8.
13. Lipsky AM, Abramovich A, Nadler R et al. Tranexamic acid in the prehospital setting: Israel Defense Forces' initial experience. Injury. 2014; 45:66-70.
14. Vu EN, Schlamp RS, Wand RT et al. Prehospital use of tranexamic acid for hemorrhagic shock in primary and secondary air medical evacuation. Air Med J. 2013; 32:289-92.
15. Hilbert P, OlafHofmann G, Teichmann J et al. The "coagulation box" and a new hemoglobin-driven algorithm for bleeding control in patients with severe multiple traumas. Arch Trauma Res. 2013; 2:3-10.